Objectives: At the end of this program, participants should be able to:
1. Review rationale for minimally invasive surgery in ICH, and prior clinical trials.
2. Present optimizations of the procedure prior to MISTIE III.
3. MISTIE III Results and who benefited.
4. Levels of evidence, lessons learned and the road ahead.
03/27/2019 - 8:30am to 9:30am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Issam A. Awad, MD, MSc, FACS, MA (hon)